France vs Iceland: Reported rate of new cervical cancer cases
France
6.89 per 100,000 women
in 2017
Iceland
6.24 per 100,000 women
in 2022
France rank
27th
Iceland rank
30th
Reported rate of new cervical cancer cases over time
- France
- Iceland
How they compare
France currently reports 6.89 per 100,000 women against 6.24 per 100,000 women in Iceland, a difference of 0.65 per 100,000 women.
That makes France's figure about 1.1 times Iceland's.
The two have swapped places 4 times across 20 shared years of data; in 1998 it was Iceland ahead.
France ranks 27th and Iceland ranks 30th of 46 countries.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | France | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 7.72 per 100,000 women | 8.57 per 100,000 women | 0.8454 per 100,000 women | Iceland |
| 2000s | 6.74 per 100,000 women | 8.54 per 100,000 women | 1.79 per 100,000 women | Iceland |
| 2010s | 6.28 per 100,000 women | 8.92 per 100,000 women | 2.65 per 100,000 women | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, France or Iceland?
- France, at 6.89 per 100,000 women against 6.24 per 100,000 women in Iceland as of 2017.
- What is the difference in reported rate of new cervical cancer cases between France and Iceland?
- 0.65 per 100,000 women, with France ahead.
- How many years of comparable data are there for France and Iceland?
- 20 years are reported by both, from 1998 to 2017.
- How do France and Iceland rank globally for reported rate of new cervical cancer cases?
- France ranks 27th and Iceland ranks 30th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.